Zhong Zheng

Zhong Zheng

Auto-generated profile, based on publicly available information

Zhong Zheng

Faculty of Humanities and Arts, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
XLXuexing Luo
Xuexing Luo
YLYiyuan Li
Yiyuan Li
JXJing Xu
Jing Xu
ZZZhong Zheng
Zhong Zheng
FYFangtian Ying
Fangtian Ying
GHGuanghui Huang
Guanghui Huang
Background: The World Health Organization reports that >1 billion people worldwide experience mental disorders, with the prevalence of depression and anxiety among children and adolescents at 2.6% and 6.5%, respectively. However, commonly used clinical questionnaires such as the Hamilton Depression Rating Scale and the Beck Depression Inventory suffer from several problems, including the high degree of overlap of symptoms of depression with those of other psychiatric disorders and a lack of professional supervision during administration of the questionnaires, which often lead to inaccurate diagnoses. In the wake of the COVID-19 pandemic, the health care system is facing the dual challenges of a surge in patient numbers and the complexity of mental health issues. Artificial Intelligence (AI) technology has now been shown to have great promise in improving diagnostic accuracy, assisting clinical decision-making, and simplifying questionnaire development and data analysis. Objective: This review aimed to explore the current applications, potential benefits, and issues of AI in medical questionnaires, focusing on its role in 3 main functions: assessment, development, and prediction. The global mental health burden remains severe. Methods: The review included peer-reviewed studies that applied AI technologies to medical, psychological, or physiological questionnaires and reported measurable outcomes; non–peer-reviewed, non-English/Chinese, ethically noncompliant, or AI-unrelated studies were excluded. Five databases (PubMed, Embase, Cochrane Library, Web of Science, and CNKI) were searched from inception through September 2024. Three independent reviewers conducted data extraction, quality appraisal using the Joanna Briggs Institute tools, and narrative synthesis of AI applications across questionnaire assessment, development, and prediction tasks. Results: Of 49,091 publications, a total of 14 (0.03%) studies met the inclusion criteria. AI technologies showed advantages in assessment, such as distinguishing myalgic encephalomyelitis or chronic fatigue syndrome from long COVID-19 with 92.18% accuracy. In questionnaire development, natural language processing using generative models such as ChatGPT was used to construct culturally competent scales. In terms of disease prediction, one study had an area under the curve of 0.790 for cataract surgery risk prediction. Overall, 24 AI technologies were identified, covering traditional algorithms such as random forest, support vector machine, and k-nearest neighbor, as well as deep learning models such as convolutional neural networks, Bidirectional Encoder Representations From Transformers, and ChatGPT. Despite the positive findings, only 21% (3/14) of the studies had entered the clinical validation phase, whereas the remaining 79% (11/14) were still in the exploratory phase of research. Most of the studies (10/14, 71%) were rated as being of moderate methodological quality, with major limitations including lack of a control group, incomplete follow-up data, and inadequate validation systems. Conclusions: In summary, the integrated application of AI in medical questionnaires has significant potential to improve diagnostic efficiency, accelerate scale development, and promote early intervention. Future research should pay more attention to model interpretability, system compatibility, validation standardization, and ethical governance to effectively address key challenges such as data privacy, clinical integration, and transparency.

9 February 2025 in JMIR Preprints
Verified
Preprint
Open access
XLXuexing Luo
Xuexing Luo
YLYiyuan Li
Yiyuan Li
JXJing Xu
Jing Xu
ZZZhong Zheng
Zhong Zheng
FYFangtian Ying
Fangtian Ying
GHGuanghui Huang
Guanghui Huang
UNSTRUCTURED This systematic review aimed to explore the current applications, potential benefits, and issues of artificial intelligence (AI) in medical questionnaires, focusing on its role in 3 main functions: assessment, development, and prediction. The global mental health burden remains severe. The World Health Organization reports that >1 billion people worldwide experience mental disorders, with the prevalence of depression and anxiety among children and adolescents at 2.6% and 6.5%, respectively. However, commonly used clinical questionnaires such as the Hamilton Depression Rating Scale and the Beck Depression Inventory suffer from several problems, including the high degree of overlap of symptoms of depression with those of other psychiatric disorders and a lack of professional supervision during administration of the questionnaires, which often lead to inaccurate diagnoses. In the wake of the COVID-19 pandemic, the health care system is facing the dual challenges of a surge in patient numbers and the complexity of mental health issues. AI technology has now been shown to have great promise in improving diagnostic accuracy, assisting clinical decision-making, and simplifying questionnaire development and data analysis. To systematically assess the value of AI in medical questionnaires, this study searched 5 databases (PubMed, Embase, Cochrane Library, Web of Science, and China National Knowledge Infrastructure) for the period from database inception to September 2024. Of 49,091 publications, a total of 14 (0.03%) studies met the inclusion criteria. AI technologies showed significant advantages in assessment, such as distinguishing myalgic encephalomyelitis or chronic fatigue syndrome from long COVID-19 with 92.18% accuracy. In questionnaire development, natural language processing using generative models such as ChatGPT was used to construct culturally competent scales. In terms of disease prediction, one study had an area under the curve of 0.790 for cataract surgery risk prediction. Overall, 24 AI technologies were identified, covering traditional algorithms such as random forest, support vector machine, and k-nearest neighbor, as well as deep learning models such as convolutional neural networks, Bidirectional Encoder Representations From Transformers, and ChatGPT. Despite the positive findings, only 21% (3/14) of the studies had entered the clinical validation phase, whereas the remaining 79% (11/14) were still in the exploratory phase of research. Most of the studies (10/14, 71%) were rated as being of moderate methodological quality, with major limitations including lack of a control group, incomplete follow-up data, and inadequate validation systems. In summary, the integrated application of AI in medical questionnaires has significant potential to improve diagnostic efficiency, accelerate scale development, and promote early intervention. Future research should pay more attention to model interpretability, system compatibility, validation standardization, and ethical governance to effectively address key challenges such as data privacy, clinical integration, and transparency.

31 October 2025 in Medicine
Verified
Journal Article
Open access
JSJifeng Shen
Jifeng Shen
JXJing Xu
Jing Xu
ZZZhong Zheng
Zhong Zheng
JWJue Wang
Jue Wang
LLLinyang Li
Linyang Li
GHGuanghui Huang
Guanghui Huang
Background: Caregivers in palliative care settings often face significant emotional and psychological burdens, yet their mental health needs remain under-addressed. Mind-body therapies (MBTs) have shown promise in clinical populations, but their effects on caregivers are understudied and poorly synthesized. Methods: This systematic review followed PRISMA 2020 guidelines and was registered with PROSPERO (CRD42024571202). A comprehensive search of PubMed, EMBASE, Web of Science, and Cochrane Library identified randomized controlled trials (RCTs) and quasi-experimental studies (QES) assessing MBTs for caregivers in palliative care. Data were extracted using the PICOS framework. Study quality was appraised using JBI tools, risk of bias was assessed via ROB2 and ROBINS-I, and evidence certainty was rated with GRADE. Results: 20 studies involving 1230 caregivers were included. Interventions encompassed 8 types of MBTs, with structured, therapist-guided formats demonstrating stronger effects than self-directed or digital approaches. Overall, MBTs showed short-term improvements in depression, anxiety, PTSD, distress, quality of life, and self-regulation. Informal and home hospice caregivers benefited most, while professional and spousal caregivers showed variable responsiveness. Methodological heterogeneity and limited follow-up constrained meta-analysis and generalizability. Conclusion: This review presents a comprehensive synthesis of existing evidence on MBTs targeting caregiver mental health in palliative care. It highlights the therapeutic potential of MBTs and identifies delivery modality and caregiver role as key moderators of intervention effectiveness. Furthermore, it contributes to the field by outlining practical implementation strategies for integrating MBTs into routine caregiver support, with an emphasis on contextual adaptation and policy-level facilitation. These findings support the development of scalable, person-centered interventions to meet the psychological needs of caregivers within palliative care systems.